Skip to main content

December 2019 Vol 12, No 8

Original Research
Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
Rajeshwari Punekar, MPH, PhD; Jeannie Choi, PharmD; Susan Boklage, MS, MPH; Melitza Iglesias-Rodriguez, MD; Kamala Nola, PharmD, MS
Read More
Perspectives, Business
The Business Case for Social Determinants
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm Adoption
Cori Gray, PharmD; James T. Kenney, RPh, MBA
Stakeholder Perspective
Outcomes-Based Contracts Gaining Traction: Innovative Therapies Will Require Innovative Payment Methods
Gary Branning, MBA
Read More

Results 1 - 3 of 3